Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
In 2017, Neelakantan and colleagues first systematically characterized 5amino1mq during screening for selective NNMT inhibitors, with findings published in Biochemical Pharmacology - marking the official discovery and public reporting of the compound.Through structural modification of quinolinebased precursors, the team identified 5amino1mq as a small, membranepermeable molecule with the chemical formula CHN.With an extremely low IC value, it became one of the most promising selective NNMT inhibitors available at the time, with high specificity and no significant inhibition of other metabolically relevant enzymes
We sincerely welcome and together we share in global resources, opening up new career together with the chapter
Kaur M, Agarwal C, Agarwal R
Nuclear Factor I-C Acts as a Regulator of Hepatocyte Proliferation at the Onset of Liver Regeneration
